Event Dates
2016-03-15 - 2016-03-17
Organizer
Website
Event contact first name
Katie
Event contact last name
Draper
Email
info@hansonwade.com
Event contact telephone number
2031418700
Attendee information
Following the previous success of our World CTC Summit meetings, Circulate will once again bring together leaders across Europe, to evaluate the latest technologies fuelling this field and explore the most recent clinical studies in circulating cancer biomarker validation. Witness first hand case studies demonstrating the impact CTCs, cfDNA, exosomes and miRNA can have on real time monitoring & personalised therapy in patient care. Understand the invaluable information that can be attained from further characterisation of CTCs and how its application could revolutionise the way we currently treat patients. With industry participation from pharma, biotechs and leading research institutes, Circulate will compliment your existing understanding with eye-opening insights into successful clinical applications. Understand the steps you need to take to advance your biomarker assay into sophisticated, cost-effective companion diagnostics. Why Attend? Evaluate the expanding market of new technologies in CTC capture, enumeration & characterisation to choose the right platform for you Learn how the industry is using characterisation of circulating cancer biomarkers to improve clinical decision making and achieve personalised treatment for patients Understand how exosomes and miRNAs can be effectively used as biomarkers for early detection and management of cancer Explore the field of companion diagnostics to understand how to advance your circulating cancer biomarkers into cost-effective clinical diagnostics